NASDAQ
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has a current ratio of 27.50x as of Monday, May 25, 2026. This represents a 58.52% increase compared to its 12-month average of 17.35x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.